Codexis Inc.
CDXS - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$130.31M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $130.31 Million |
|---|---|
| Enterprise Value | $176.59 Million |
| Earnings per Share | $-0.5 |
| Beta | 2.55 |
| Outstanding Shares | 91,053,000 |
Return
| Return on Equity | -93.22% |
|---|---|
| Return on Assets | -25.59% |
| Return on Invested Capital | -28.22% |
Valuation & Multiples
| P/E Ratio | -3.54 |
|---|---|
| PEG | 37.11 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 2.27 |
| Enterprise Value to EBIT | -6.48 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.42 |
| Debt to Equity | 2.23 |
Revenue Sources
No data
Last Earnings Call
Report Date
October 29, 2026
EPS Estimate
$-0.09
Consensus analyst estimateRevenue Estimate
$18.92 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.10
Consensus analyst estimateRevenue Estimate
$18.72 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.75%▼ 70.76% |
|---|---|
| Total Invested | $944,605▼ 99.36% |
| Investors Holding | 11▼ 140.00% |
About Codexis Inc.
146 employees
CEO: Alison Moore
Codexis, Inc. specializes in the invention, advancement, and commercialization of enzymes and various other proteins. Their diverse portfolio encompasses biocatalyst solutions, chemical intermediates designed for subsequent processing, a...